Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Corbus Pharmaceuticals: Q1 Earnings Insights

  Corbus Pharmaceuticals (NASDAQ:CRBP) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

 

Corbus Pharmaceuticals (NASDAQ:CRBP) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Corbus Pharmaceuticals reported in-line EPS of $-0.08 versus an estimate of $-0.08.

Revenue was down $647.82 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 7.97% increase in the share price the next day.

Here’s a look at Corbus Pharmaceuticals’s past performance:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.11 -0.11 -0.12 -0.15
EPS Actual -0.08 -0.02 -0.15 -0.14
Revenue Estimate 350.00K 650.00K 870.00K 960.00K
Revenue Actual 0 97.32K 136.56K 647.82K

To track all earnings releases for Corbus Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares